-

N.B.: Different languages can express different contents  -  (Italiano  English)

 

Patients are unaware of the impact of smoking on their inflammatory bowel disease (2015-08-20)

Doctors know smoking can increase the risk for certain common inflammatory bowel diseases (IBD), but many patients haven’t gotten the message, a new study suggests.
Tobacco is one of the most significant risk factors for inflammatory bowel disease (IBD).

Previous research has linked smoking to an increased risk of Crohn’s disease and its complications but has also suggested that smokers are at lower risk for ulcerative colitis, Ducharme-Benard and colleagues note in the Journal of Clinical Gastroenterology.

The main objective of this new study was to assess the knowledge of patients with IBD regarding the effects of tobacco on their disease. Secondary objectives were to determine the source of their knowledge, the influence of their knowledge on their intent to quit smoking, and the association between patients' characteristics and their knowledge.

In total 259 patients, 182 with Crohn's disease, 77 with ulcerative colitis (UC), participated.
The prevalence of current smokers, exsmokers, and nonsmokers was 19.6%, 40.2%, and 40.2%, respectively. Most patients in the study were white and female, and they were typically in their 40s.

Compared to patients with ulcerative colitis, patients with Crohn’s used more corticosteroids and other medications to manage symptoms, and they had more hospital admissions, surgeries, and time missed from work as a result of their disease.

Patients with Crohn's disease were more aware of the effects of tobacco on their disease compared with those with UC (57.7% vs. 13.0%).
In informed patients, the main source of information was the gastroenterologist (56.9%).
The intent to quit smoking was superior in informed patients compared with those uninformed (78.6% vs. 47.8%).

Older patients and patients with UC were less likely to be informed.

Only half of patients with IBD are aware of the risks of smoking associated with their disease, whereas their intent to quit smoking is directly related to their awareness. In the scope of IBD's treatment, management of smoking cessation should be undertaken in all smokers.

For more information
Journal of Clinical Gastroenterology
Patients With Inflammatory Bowel Disease are Unaware of the Impact of Smoking on Their Disease
doi: 10.1097/MCG.0000000000000386

MDN